RN7SL545P

Across TCGA pan-cancer cohorts, RN7SL545P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RN7SL545P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RN7SL545P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL545P expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

BLCA, SARC, and LUAD are the cancer types where RN7SL545P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.074	0.720	<.001	144	view →
SARC	OS	Tertile	All	0.126	0.860	<.001	36	view →
LUAD	OS	Tertile	III,IV	0.223	0.677	.006	27	view →
STAD	DFS	Tertile	All	0.676	0.330	.024	21	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RN7SL545P–BLCA (OS)

Open the BLCA breakdown →